Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Post by Benedict16thon Sep 13, 2019 11:26am

140 Views

Post# 30123806

Prediction ???

I may be wrong "not the first time", but the way GUD price is behaving and given Meir silence may indicate that Meir and JG may have reached a deal, swap GUD for Medison and each go their own way. The is no material reason or news other the the price to move towards $8. The ticker is always a good indicator of things to come

Bullboard Posts

Bitcoin Well increases reserve amid strong subscriber growth